| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.6M | +8.8% |
| Cost of Revenue | $167K | +15.1% |
| Gross Profit | $1.4M | +8.1% |
| R&D Expense | $15K | -32.1% |
| SG&A Expense | $1.4M | +13.5% |
| Operating Income | -$9K | -122.8% |
| Interest Expense | $13K | — |
| Pre-tax Income | -$107K | -69.5% |
| Net Income | -$107K |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $106K | +84.4% |
| Accounts Receivable | $245K | +14.0% |
| Inventory | $222K | -5.1% |
| Current Assets | $696K | +19.1% |
| Total Assets | $998K | +0.6% |
| Current Liabilities | $4.5M | +10.4% |
| Total Liabilities | $4.7M | +8.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $60K | +104.2% |
| Capital Expenditures | $4K | -55.3% |
| Investing Cash Flow | -$4K | +55.3% |
| Financing Cash Flow | -$8K | -3680.1% |
| Free Cash Flow | $56K | +178.9% |
| -53.8% |
| EPS (Basic) | -$0.01 | +0.0% |
| EPS (Diluted) | -$0.01 | +0.0% |
| Stockholders' Equity |
| -$3.7M |
| -11.0% |